Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity
- 3 December 2005
- journal article
- research article
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 11 (2), 131-138
- https://doi.org/10.1007/s00775-005-0053-x
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Synthesis, structure and spectroscopy of new thiopyrone and hydroxypyridinethione transition-metal complexesDalton Transactions, 2005
- Group 13 and Lanthanide Complexes with Mixed O,S Anionic Ligands Derived from MaltolInorganic Chemistry, 2005
- Addressing Lead Toxicity: Complexation of Lead(II) with Thiopyrone and Hydroxypyridinethione O,S Mixed ChelatorsInorganic Chemistry, 2004
- Using Model Complexes To Augment and Advance Metalloproteinase Inhibitor DesignInorganic Chemistry, 2004
- Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding groupJBIC Journal of Biological Inorganic Chemistry, 2004
- Metal Complexes of thetrans-Influencing Ligand ThiomaltolInorganic Chemistry, 2003
- Early Short-Term Treatment With Doxycycline Modulates Postinfarction Left Ventricular RemodelingCirculation, 2003
- Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3′ group chiralityBioorganic & Medicinal Chemistry Letters, 2001
- Hydroxamic acids are nitric oxide donors. Facile formation of ruthenium(II)-nitrosyls and NO-mediated activation of guanylate cyclase by hydroxamic acidsChemical Communications, 2000
- Captopril: Pharmacology, Metabolism, and DispositionDrug Metabolism Reviews, 1984